Dipna Pharmachem Limited has made a regulatory disclosure pursuant to Regulation 30(6) of the SEBI (LODR) Regulations, 2015. The company's Board of Directors held a meeting on Wednesday, 1st July, 2026, which commenced at 4:00 P.M. and concluded at 7:00 P.M. at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad – 380 055.

During this meeting, the Board decided to reschedule the meeting to Thursday, 2nd July, 2026 at 04:00 P.M. at the same Registered Office location. The purpose of the rescheduled meeting is to discuss and consider, inter-alia:

  • The Audited Financial Results of the Company for the Half Year and Year ended on 31st March, 2026 along with Auditor's Report
  • Any other matter to be discussed and considered with the permission of the Chairperson of the Board Meeting

The disclosure was signed by Keyur Shah, Managing Director (DIN: 03167258), and submitted to BSE Limited on 1st July, 2026 at 19:15:08 IST.